Black Diamond Therapeutics, Inc. BDTX Q2 2025 earnings
Reported August 7, 2025 · Before market open
EPS-$0.19Beat by $0.06
EPS estimate-$0.25
Next report
Aug 6, 2026 (In 1 week)EPS estimate-$0.18
Versus estimates
Revenue
Diluted EPS
Ask the moment Black Diamond Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Black Diamond Therapeutics, Inc. report Q2 2025 earnings?
- Black Diamond Therapeutics, Inc. (BDTX) reported Q2 2025 earnings on August 7, 2025 before market open.
- What were Black Diamond Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- Black Diamond Therapeutics, Inc. reported eps of $-0.19 for Q2 2025.
- Did Black Diamond Therapeutics, Inc. beat estimates in Q2 2025?
- EPS beat the consensus estimate of $-0.25 by $0.06.
- How did Black Diamond Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 47.2% from $-0.36.
- Where can I find Black Diamond Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001701541-25-000030) directly on SEC EDGAR. The filing index links above go to sec.gov.